These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1384935)

  • 41. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 42. The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Finnegan KT; Skratt JJ; Irwin I; Langston JW
    Neurosci Lett; 1989 Nov; 105(3):300-6. PubMed ID: 2574428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?
    Scheffel U; Ricaurte GA
    Brain Res; 1990 Sep; 527(1):89-95. PubMed ID: 1980843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
    Nash JF; Yamamoto BK
    Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G; Sharkey J; Kuhar MJ; de Souza EB
    Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Tucker G
    Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD; Katz JL; Ricaurte GA
    Brain Res; 1992 Sep; 589(2):349-52. PubMed ID: 1382813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.
    Schmidt CJ; Taylor VL
    Eur J Pharmacol; 1990 May; 181(1-2):133-6. PubMed ID: 1974853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives.
    Bronson ME; Barrios-Zambrano L; Jiang W; Clark CR; DeRuiter J; Newland MC
    Drug Alcohol Depend; 1994 Dec; 36(3):161-6. PubMed ID: 7889806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.
    Goñi-Allo B; Puerta E; Mathúna BO; Hervias I; Lasheras B; de la Torre R; Aguirre N
    Neuropharmacology; 2008 Apr; 54(5):885-900. PubMed ID: 18329670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-activity relationships of MDMA-like substances.
    Nichols DE; Oberlender R
    NIDA Res Monogr; 1989; 94():1-29. PubMed ID: 2575223
    [No Abstract]   [Full Text] [Related]  

  • 55. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
    Scanzello CR; Hatzidimitriou G; Martello AL; Katz JL; Ricaurte GA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1484-91. PubMed ID: 7680719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates.
    Ricaurte GA; DeLanney LE; Wiener SG; Irwin I; Langston JW
    Brain Res; 1988 Dec; 474(2):359-63. PubMed ID: 2463059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ; Black CK; Abbate GM; Taylor VL
    Brain Res; 1990 Oct; 529(1-2):85-90. PubMed ID: 1980848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Hegadoren KM; Baker GB; Coutts RT
    J Pharmacol Toxicol Methods; 1995 Oct; 34(2):117-23. PubMed ID: 8563033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.